Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients

Abstract

Decreased serum tryptophan concentrations and elevated serum neopterin levels can be used as predictive markers for the future course in melanoma patients. Moreover, our data support previous speculations that a higher degree of IDO expression could play a crucial role for tumor progression.